ButCoIns - Metabolic Effects of Resistent Starch and Arabinoxylans in Subjects With Metabolic Syndrome

Launched by AARHUS UNIVERSITY HOSPITAL · Apr 24, 2012

Keywords

ClinConnect Summary

Background Life style related disease is an increasing problem all over the world. The Metabolic Syndrome (MetS) is a condition characterized by abdominal obesity, dyslipidemia, hypertension and impaired glucose tolerance. Subjects with MetS have high risk of developing Type 2 Diabetes and CVD.

Resistant Starch (RS) and Arabinoxylans (AX) are dietary fibers that have been shown to have positive effects on the components of MetS. The combination of RS and AX has not been tested before .

Hypotheses Increase of RS and AX in the dietary composition has a positive effects on components of MetS...

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: At least 3 out of the 5 following criterions
• • Central obesity (Female \>80 cm, Male \>94)
• • HDL cholesterol (female \< 1,03 mmol/l, male \< 1,29 mmol/l)
• • Blood Pressure (\> 130/85)
• • Fasting Blood Glucose \> 5,6 mmol/L
• Exclusion Criteria:
• • Diabetes
• • Gastrointestinal disease
• • Anticoagulation treatment
• • Serious liver, heart or kidney disease
• • Anaemia
• • Corticosteroid treatment
• • Waist circumference above 130 cm
• • Alcohol or drug addiction
• • Pregnancy og lactation